Harvest Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Buy |
+1,125
| New | +$366K | 0.02% | 275 |
|
|
2024
Q4 | – | Sell |
-162
| Closed | -$45K | – | 730 |
|
|
2024
Q3 | $45K | Buy |
+162
| New | +$45K | ﹤0.01% | 465 |
|
|
2024
Q1 | – | Sell |
-23
| Closed | -$4K | – | 658 |
|
|
2023
Q4 | $4K | Hold |
23
| – | – | ﹤0.01% | 579 |
|
|
2023
Q3 | $4K | Hold |
23
| – | – | ﹤0.01% | 571 |
|
|
2023
Q2 | $4K | Sell |
23
-95
| -81% | -$16.5K | ﹤0.01% | 602 |
|
|
2023
Q1 | $24K | Sell |
118
-283
| -71% | -$57.6K | 0.01% | 558 |
|
|
2022
Q4 | $95K | Buy |
+401
| New | +$95K | 0.02% | 342 |
|
|
2022
Q2 | – | Sell |
-342
| Closed | -$55K | – | 712 |
|
|
2022
Q1 | $55K | Sell |
342
-532
| -61% | -$85.6K | 0.01% | 414 |
|
|
2021
Q4 | $148K | Hold |
874
| – | – | 0.03% | 290 |
|
|
2021
Q3 | $165K | Buy |
874
+783
| +860% | +$148K | 0.04% | 188 |
|
|
2021
Q2 | $15K | Hold |
91
| – | – | ﹤0.01% | 668 |
|
|
2021
Q1 | $12K | Buy |
+91
| New | +$12K | ﹤0.01% | 735 |
|
|
2020
Q4 | – | Sell |
-928
| Closed | -$131K | – | 578 |
|
|
2020
Q3 | $131K | Buy |
928
+380
| +69% | +$53.6K | 0.01% | 229 |
|
|
2020
Q2 | $81K | Sell |
548
-414
| -43% | -$61.2K | 0.01% | 265 |
|
|
2020
Q1 | $104K | Sell |
962
-46
| -5% | -$4.97K | 0.01% | 197 |
|
|
2019
Q4 | $119K | Buy |
+1,008
| New | +$119K | 0.01% | 160 |
|